3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
121
Carcinoma, Renal Cell
60
Neoplasms
43
Liver Neoplasms
42
Neoplasm Metastasis
23
Carcinoma, Non-Small-Cell Lung
21
Leukemia, Myeloid, Acute
20
Melanoma
18
Kidney Neoplasms
16
Breast Neoplasms
16
Brain Neoplasms
13
Pancreatic Neoplasms
12
Sarcoma
11
Prostatic Neoplasms
10
Glioblastoma
10
Lung Neoplasms
9
Thyroid Neoplasms
8
Recurrence
8
Rectal Neoplasms
8
Colorectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Colonic Neoplasms
7
Stomach Neoplasms
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Leukemia
6
Gliosarcoma
6
Carcinoma
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Urinary Bladder Neoplasms
4
Interventions
Gemcitabine
9
Cisplatin
5
vinflunine
4
Carboplatin
4
pembrolizumab
2
enfortumab vedotin
2
Ramucirumab
2
Platinum
2
Docetaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
genexol-PM
1
eribulin
1
enzalutamide
1
dehydroftorafur
1
carotuximab
1
avelumab
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiation
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Molecular Diagnostic Techniques
1
Mitozytrex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Ureteral Neoplasms
×
Sorafenib
×
Clear all
NCT01844947
2019-04-26
VINSOR
Karolinska University Hospital
Phase 1
Completed
22 enrolled